| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.37B | -15.2% |
| Cost of Revenue | $4.02B | -14.8% |
| Gross Profit | $350.0M | -19.2% |
| R&D Expense | $79.0M | -44.0% |
| SG&A Expense | $238.0M | +30.8% |
| Operating Income | -$287.0M | +10.3% |
| Pre-tax Income | -$1.30B | -232.5% |
| Income Tax | $0 | -100.0% |
| Net Income | -$1.30B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $962.0M | +43.4% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $2.30B | -23.3% |
| Total Assets | $2.41B | -23.0% |
| Current Liabilities | $327.0M | -38.2% |
| Total Liabilities | $1.40B | -41.9% |
| Stockholders' Equity | $1.00B | +41.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.05B | +276.3% |
| Capital Expenditures | $12.0M | -52.0% |
| Investing Cash Flow | -$12.0M | -142.9% |
| Financing Cash Flow | -$499.0M | -137.6% |
| Free Cash Flow | $1.04B | +267.3% |
| -231.6% |
| EPS (Basic) | -$1.70 | -203.6% |
| EPS (Diluted) | -$1.70 | -203.6% |